Anaplastic thyroid cancer (ATC) is an uncommon malignancy of the thyroid. Only 1‐2% of
thyroid cancers are anaplastic, but the disease contributes to 14–50% of the mortality with a …

Introduction Over the past years, the incidence of thyroid cancer has surged not only in
Germany but also in other countries of the Western hemisphere. This surge was first and …

Background Anaplastic thyroid carcinoma (ATC) accounts for only 1 to 2% of all thyroid
carcinomas, but it is one of the most lethal neoplasms in humans. To date, most findings …

Anaplastic thyroid cancer (ATC) is a rare malignancy. While external beam radiation therapy
has improved locoregional control, the median survival of∼ 4 months has not changed in …

Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly
patients. There is often a history of previous differentiated thyroid cancer suggesting a …

Background Anaplastic thyroid carcinoma (ATC) is one of the most aggressive solid tumors
known to affect humans and carries a dismal prognosis. Our primary aim was to review its …

Background: Anaplastic thyroid cancer (ATC) is one of the most lethal forms of cancer with a
high mortality rate. Current guidelines support surgery for resectable ATC followed by …

Background Poorly differentiated thyroid carcinoma (PDTC) and anaplastic
(undifferentiated) thyroid carcinoma (ATC) comprise a small subset of thyroid tumors that are …

Anaplastic thyroid cancer is an uncommon, typically lethal malignancy of older adults with
no effective systemic therapy. The mean survival time is usually less than 6 months from the …

PURPOSE: To analyze a prospective protocol combining surgery, chemotherapy (CT), and
hyperfractionated accelerated radiotherapy (RT) in anaplastic thyroid carcinoma. METHODS …